Ameriprise Financial, Inc. 13D and 13G filings for Anika Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 10:33 am Sale |
2022-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
AMERIPRISE FINANCIAL INC AMP |
181,943 1.250% |
-805,790 (-81.58%) |
Filing |
| 2022-02-14 12:27 pm Sale |
2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
AMERIPRISE FINANCIAL INC AMP |
987,733 6.840% |
-16,375 (-1.63%) |
Filing |
| 2021-02-12 09:45 am Purchase |
2020-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
AMERIPRISE FINANCIAL INC AMP |
1,004,108 7.070% |
1,004,108 (New Position) |
Filing |